Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain

Antoni Sicras-Mainar,1 Javier Rejas-Gutiérrez,2 Ruth Navarro-Artieda3 1Planning Directorate, Badalona Serveis Assistencials SA, Badalona, Barcelona, Spain; 2Department of Health Economics and Outcomes Research, Pfizer SLU, Alcobendas, Madrid, Spain; 3Medical Documentation, Hospital German...

Full description

Bibliographic Details
Main Authors: Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/comparative-effectiveness-and-costs-of-generic-and-brand-name-gabapent-peer-reviewed-article-CEOR